Has the Opportunity for Canopy Growth Corp. Passed?

Primarily through a series of well-executed acquisitions and partnerships, Canopy Growth Corp. (TSX:WEED) is now more well positioned to excel in the upcoming legal marijuana market than ever before.

| More on:

Over the past year, impending legalization has helped to propel cannabis stocks such as Canopy Growth Corp. (TSX:WEED) to new highs. As we begin to move closer to that impending legalization date, many investors are now questioning if that opportunity — particularly for the market leader Canopy Growth — has passed.

Let’s take a look at the stock and try to answer that question.

Here’s the opportunity, and why Canopy is in prime position

Voting on legalization is set to happen next month, with a likely passage through the houses, and marijuana will become available for purchase by consumers sometime in August or September. In terms of opportunity, the current investment market for cannabis stocks has been compared with an investment in a liquor company at the end of prohibition.

To capitalize on that opportunity, Canopy is often regarded as the clear market leader of this emerging segment due to the following three reasons.

First, Canopy has a production capacity that far surpasses its competitors. Canopy’s 2.4 million square feet of licensed growing space represents a significant boost over the company’s growing capabilities from just earlier this year, and Canopy expects to continue increasing that growing space to at least three million square feet or higher before the end of the year.

By way of comparison, Canopy’s primary competitors have less than half the capacity of Canopy.

Second, Canopy has, without a doubt, one of the most impressive and far-reaching distribution channels in the emerging sector.  Securing agreements to serve different markets, provinces, or even countries has established a moat around Canopy that will only become harder to pierce in time.

Canopy already has access to the German market through its subsidiary, Spektrum Cannabis GmbH. There’s also the recently announced acquisition of Annabis Medical, a Czech-based leader in the medical cannabis industry. That acquisition follows a recent supply partnership established with Spanish pharmaceutical giant Alcaliber S.A.

There are also the agreements forged right here in Canada that Canopy has forged with both the provinces of Newfoundland and Labrador as well as New Brunswick. More recently, Canopy signed a multi-year agreement to provide cannabis to the Société des alcools du Québec.

Investors should expect more of these deals at both the domestic and international level as Canopy continues to flex its muscle.

Finally, Canopy is already thinking about growth into other verticals. Last fall, beverage behemoth Constellation Brands Inc. purchased a 10% stake in Canopy, and the purchase widely viewed as a means for the two companies to work together on developing infused beverages for sale where legal to do so.

With Constellation already serving the U.S., Canada, Italy, Mexico, and New Zealand, the possibilities for expansion once permissible by law are huge, and the cash infusion into Canopy will be used to further develop Canopy’s growing capacity even further.

In my opinion, Canopy remains an excellent investment opportunity in an emerging industry.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Demetris Afxentiou has no position in any stocks mentioned.

More on Investing

Blocks conceptualizing Canada's Tax Free Savings Account
Investing

Boost Your Portfolio With 2025’s TFSA Contribution Room

High-yield stocks like First National Financial (TSX:FN) held in a TFSA, can boost your portfolio.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Stocks for Beginners

TFSA: 4 Canadian Stocks to Buy Now and Hold Forever

These Canadian stocks are top notch for investors wanting to gain access to a diversified portfolio for the long run.

Read more »

A worker drinks out of a mug in an office.
Tech Stocks

Rebalancing Your Portfolio for 2025? 3 Growth Stocks to Consider

Here are three of the best growth stocks Canada has to offer and why these gems may be worth buying…

Read more »

data analyze research
Dividend Stocks

Outlook for BCE Stock in 2025

If BCE successfully turns around, over the next few years, new investors could pocket some nice income and capital gains.

Read more »

Piggy bank wrapped in Christmas string lights
Investing

Build Wealth With 2025’s New TFSA Contribution Room Limits

Are you wondering how to take advantage of $7,000 of new TFSA contribution space in 2025? Look for stocks that…

Read more »

dividends can compound over time
Stock Market

The Hottest Sectors for Canadian Investors in 2025

From current momentum to the political climate, several factors can help investors identify the right sectors to invest in 2025.

Read more »

Pile of Canadian dollar bills in various denominations
Stocks for Beginners

Is Royal Bank of Canada Stock a Buy for its 3.3% Dividend Yield?

Royal Bank stock has long been one of the best buys on the TSX, and that remains the case after…

Read more »

cloud computing
Dividend Stocks

Safe Stocks to Buy in Canada for December

Given their solid underlying businesses and healthy growth prospects, these three safe stocks are excellent buys this month.

Read more »